What topics does this cannabis study cover?

This study covers research on: THC.

Where was this research published?

Published in Cannabis and cannabinoid research on June 10, 2026.

THC

Doctor-recommended cannabis use drops by half after legalization

Doctor-Recommended Cannabis Use in the Era of Legalization: Trends from California (2019-2024).

Cannabis and cannabinoid research • June 10, 2026 • Moderately Relevant

🤖

AI Summary

California's recreational cannabis legalization has fundamentally altered how people access and use cannabis, with major consequences for medical oversight. Between 2019 and 2024, doctor-recommended cannabis use among past-month users dropped from 18.5% to 8.5%—a decline of more than half—while overall cannabis use remained relatively stable at around 15-16% of the population. This shift suggests that as recreational dispensaries became widely available, individuals increasingly turned to the commercial marketplace without medical guidance, effectively displacing formal healthcare involvement in cannabis use decisions.

The decline in physician oversight became particularly pronounced starting in 2021 and was consistent across most demographic groups, including men, women, and most racial and ethnic communities. However, the pattern was less clear among young adults (18-25) and some racial/ethnic minorities, suggesting that access and utilization patterns may vary by demographic factors. The researchers emphasize that this trend carries important health implications: individuals with complex medical conditions may now be using cannabis from the recreational market without clinician guidance, losing the potential benefits of professional medical advice about drug interactions, appropriate dosing, and condition-specific suitability.

This research highlights a critical tension in the legalization era. While overall cannabis use has not increased substantially, the mechanism of access has fundamentally changed. Rather than reducing cannabis use, legalization and commercialization have redirected users away from medical cannabis programs toward the recreational market. This represents a significant shift in public health oversight, raising concerns about whether vulnerable populations with chronic conditions are receiving adequate medical supervision for their cannabis use.

📄 Original Abstract

California legalized medical cannabis in 1996 and nonmedical adult use in 2016, with commercial recreational sales starting in 2018. The consequences of cannabis legalization and commercialization on medical cannabis utilization are not well understood. We analyzed data from 178,832 adults (aged ≥18 years) in the California Health Interview Survey (2017-2024). Past-month cannabis use and doctor-recommended use were assessed each year. We fit survey-weighted logistic regression models with year as a categorical predictor, used omnibus Wald tests to assess whether prevalence differed across years, and estimated year-to-year differences with Tukey-adjusted contrasts. All analyses accounted for survey weights, strata, and primary sampling units. Between 2019 and 2024, about 1.6% of all respondents and 16.4% of past-month cannabis users reported doctor-recommended use. Among past-month users, doctor-recommended use fell from 18.5% (95% Confidence Interval [CI]: 16.6%-20.4%) in 2019 to 8.5% (95% CI: 7.3%-9.8%) in 2024 (p < 0.01). Overall past-month cannabis use held steady, at 16.5% (95% CI: 15.5%-17.6%) in 2019 and 15.4% (95% CI: 14.5%-16.2%) in 2024 (p = 0.22). Tukey-adjusted comparisons showed the decline was most apparent from 2021 onward. The pattern held across sex and most age and racial/ethnic groups, though differences did not reach statistical significance among young adults aged 18-25 (-7.6 percentage points; p = 0.09), Asian respondents (-2.9 percentage points; p = 0.62), or African American respondents (-8.8 percentage points; p = 0.47). After adult-use legalization and commercialization, doctor-recommended use decreased by more than half among past-month cannabis users, even as overall use remained stable. The decline in doctor-recommended use suggests that legalization and commercialization in California may have altered patterns of medical utilization without reducing population-level use. Together, these findings align with broader national trends in which recreational access may be displacing formal medical oversight. This reduction in physician oversight raises the concern that individuals with complex medical conditions may increasingly rely on the recreational marketplace without the benefit of clinician guidance.